Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 10:04 ET | Source: ADvantage Therapeutics, Inc.

Klothea Bio Collaborates with Healthy Longevity Clinic, a Top 40 Semifinalist in $101 million XPRIZE Healthspan Competition

MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- Klothea Bio Inc., a biotechnology company pioneering mRNA-based therapies to upregulate the anti-aging protein Klotho, today announced its ongoing...
November 25, 2024 09:41 ET | Source: ADvantage Therapeutics, Inc.

Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics

MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Advantage Therapeutics Inc., a leader in developing therapies targeting age-related diseases, announced today the formation of its new subsidiary, Klothea...
September 09, 2024 10:01 ET | Source: ADvantage Therapeutics, Inc.

ADvantage Therapeutics, Inc. Welcomes Dr. William A. Haseltine as Strategic Advisor to Drive Innovation in Alzheimer's Disease Research and Anti-aging Therapies such as Klotho Protein Supplementation to Extend Healthy Human Lifespan

MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a leading clinical-stage biotechnology company dedicated to the advancement of innovative therapies for Alzheimer's disease,...
October 02, 2023 10:43 ET | Source: Advantage Therapeutics Inc.

ADvantage Therapeutics Welcomes Esteemed Expert in Alzheimer’s Disease and Klotho Protein, Carmela Abraham, Ph.D. as Chief Science Officer

ADvantage Therapeutics appoints Dr. Carmela Abraham as Chief Science Officer
March 24, 2023 08:45 ET | Source: Advantage Therapeutics Inc.

Renowned Public Health Advisor Jim O’Neill Joins Board of Directors of ADvantage Therapeutics

BOCA RATON, Fla. and VIENNA, Austria, March 24, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), which is developing therapies to treat neurodegenerative...